Company profile

Oncorena company profile

Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity and other clinical benefits in patients with advanced kidney cancer.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$0+
Founded
2011-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$22.9M
Last funding
Series Unknown / $14M / 2025-06-26
Last equity funding
Series Unknown / $14M
Investors
4
Lead investors
2
Founders
1
Articles
15

Founders and investors

Founders

Jenny Nyström

Lead investors

HealthCapPartners for Development investments in Life Sciences

Investors

Fåhraeus Startup and GrowthHealthCapLincPartners for Development investments in Life Sciences

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.